Applied DNA Sciences Inc. (OTCBB: APDN)
Monday, July 25, 2011 at 11:22AM 
Applied DNA Sciences Inc. (OTCBB: APDN) sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators.
Applied DNA Sciences (APDN) is the only company in the world that is making use of the complex codes embedded in botanical DNA as the ultimate solution to counterfeiting.
Counterfeiting is one of the fastest growing financial crimes, threatening jobs and endangering public health and safety. The World Customs Organization estimated annual global trade in illegitimate goods at about $600 billion (2004), which is expected to double to $1.2 trillion by 2014, representing 5% to 7% of all worldwide trade.
DNA is a trusted form of forensic evidence, widely accepted by courts around the world. Applied DNA provides unique solutions that will stand the test of time - Absolute. Simple. Affordable. Green.
Driven by its two anti-counterfeiting security platforms, SigNature® DNA and BioMaterial Genotyping™, APDN can service a multitude of industries including cash-in-transit, textiles and apparel, secure documents for military and homeland security, pharmaceuticals, wine, and other luxury items.
Botanically derived SigNature® DNA markers, authentication services and DNA-marked security inks such as cash degradation, intaglio, inkjet, thermal transfer, laser toner and a wide range of security varnishes, dyes and textiles treatments are now available. BioMaterial Genotyping™, can help determine the authenticity of natural materials used in finished products by detecting and identifying their genomic DNA.
DNA is the Ultimate Reality Check, and we invite you to learn more about the benefits of DNA and how Applied DNA can customize a solution for you.
Editor
Applied DNA ($APDN) closes $5.0 million institutional financing
Applied DNA Sciences (OTCBB: APDN; Twitter: $APDN) closed this week on a $5.0 million institutional round of financing via a private placement sale of its common stock. APDN issued and sold 105,263,158 shares of common stock at a purchase price of $0.0475 per share to for gross proceeds of $5,000,000. The Etico Capital division of Halcyon Cabot Partners Ltd., a registered broker dealer, was the placement agent. APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators.
Why Now?
The company's revenues have grown, and APDN recently gained a significant contact with the US Department of Defense to:
"fully engage one of the government's microchip supply chains. APDN has "completed a program to DNA mark microchips for the Defense Logistics Agency of the U.S. Department of Defense."
In addition, APDN is now see a variety of applications from different markets. One example is Martin Guitar, who is known for the finest guitars in the world for over 175 years. As stated in this week's press release, APDN will protect Martin's products, brands and intellectual property from counterfeiting and diversion:
"Martin's customers will be protected by the "gold standard" in forensic anti-counterfeiting systems."
In order to support this growing demand, Applied DNA Sciences closed on the $5.0 million in additional capital, and the company is now positioned to fully capitalize on the significant market opportunity for its security solutions.
Two investors, who contributed the majority of the funding, bring their years of experience and expertise to the company:
- Gerald Catenacci of Neustrada Capital; and
- John Bitzer, III of Abarta will join the Board of Directors within 30 days.
Quotes from the Press Release:
"APDN is well poised to dominate the demand for source authentication. We are confident the company will continue to add key accounts, satisfy marquee customers, and integrate technologies into multiple industry verticals." - Gerald Catenacci
"Raising our first round of institutional capital in this economic environment is a true testament to the hard work of our team. In a time of extraordinary market pressure, we are steadily growing and redefining what customers expect from security technology solutions." - Dr. James Hayward, President and CEO of APDN
To learn more, go to www.adnas.com.